Pharmacotherapy of Erectile Dysfunction Flashcards
Define Erectile Dysfunction
Inability to maintain penile erection sufficient for penetration to permit satisfactory sexual intercouse
Psychogenic Causes of ED
Generalized unresponsiveness or inhibition
Situational (performance)
Psychological (mood, stress)
Organic Causes of ED
Neurogenic (stroke, parkinson’s, DM, ETOH, Spinal cord injury)
Vascular (PVD, arteriosclerosis, HTN, trauma)
Hormonal (decreased T, hyperprolactinemia, hypothyroidism, hyperthyroidism)
Medication induced
Drugs that Induce ED
Anticholinergics Antidepressants Antipsychotics Dopamine antagonists Estrogens Antiandrogens CNS depressants Antihypertensives Cigarette and alcohol use
Diagnosis
Severity Complete medical and surgical history Review of meds PE Labs
International Index of Erectile Function
15 objective questions (erectile function, orgasmic function, sexual desire, intercourse satisfaction, overall satisfaction
5 categories of severity
PDE5 Inhibitors
First line therapy
Effective, PO, low side effect, discreet
PDE5 Inhibitor MOA
Normally PDE5 breaks down cGMP which increase calcium which causes SM contraction which decreases blood flow leading to flaccid penis
Inhibitors block this
***PDE6 Side Effects
Photoreceptor in the retine leading to increase sensitivity to light, blurred vision, loss of blue green differentiation
PDE11 Selective (Tadalafil) Side Effect
Skeletal muscle leading to back and muscle pain
PDE5 Inhibitor COntraindication
Nitrate use (hypotension)
PDE5 Inhibitor Precautions
Erection > 4 hours can lead to necrosis bc of lack of blood flow
CAD possibility (R vs B)
Hypotension and fluid depletion may be potentiated
PDE5 SE
Headache, dizzy, flushing dyspepsia Priapism (erection > 4 hrs) Hearing impairment Visual disturbances Back pain Nonarteritic anterior ischemic optic neuropathy
Nonarteritic anterior ischemic optic neuropathy
Blood flow blocked to the optic nerve
Rapid onset of painless unilateral vision loss
NAION RF
Other visual problems
Longer PDE5 Inhibitor use
PDE5 Inhibitor Interactions
CYP 3A4 inhibitors
Antihypertensives
Alcohol